World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us
Heidelberg University Hospital
Rush University Medical Center
Brigham and Women's Hospital, Harvard Medical School, USA
New CAR-T Therapy CB-010, Granted Two FDA Designations And Three Patients Are Cancer-Free For Six Months!
Can Head And Neck Cancer Recur After Treatment? What Is The Treatment For Recurrence?
